Skip to main content
Top
Published in: Journal of General Internal Medicine 1/2016

01-01-2016 | Original Research

Influence of Nephrologist Care on Management and Outcomes in Adults with Chronic Kidney Disease

Authors: Ana C. Ricardo, MD, MPH, Jason A. Roy, PhD, Kaixiang Tao, PhD, Arnold Alper, MD, MPH, Jing Chen, MD, MSc, Paul E. Drawz, MD, MHS, Jeffrey C. Fink, MD, MS, Chi-yuan Hsu, MD, MSc, John W. Kusek, PhD, Akinlolu Ojo, MD, PhD, Martin Schreiber, MD, Michael J. Fischer, MD, MSPH, on behalf of the CRIC Study Investigators

Published in: Journal of General Internal Medicine | Issue 1/2016

Login to get access

ABSTRACT

BACKGROUND

Predialysis nephrology care for adults with late stage chronic kidney disease (CKD) is associated with improved outcomes. Less is known about the effects of nephrology care in earlier stages of CKD.

OBJECTIVE

We aimed to evaluate the effect of nephrology care on management of CKD risk factors and complications, CKD progression, incident cardiovascular disease (CVD), and death.

DESIGN

This was a prospective cohort study.

PARTICIPANTS

Participants included 3855 men and women aged 21 to 74 years enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study with a mean (SD) estimated glomerular filtration rate (eGFR) at entry of 45 (17) ml/min/1.73 m2, followed for a median of 6.6 years.

MAIN MEASURES

The main predictor was self-reported prior contact with a nephrologist at study enrollment. Outcomes evaluated included CKD progression (≥ 50 % eGFR loss or end-stage renal disease), incident CVD, and death.

RESULTS

Two-thirds (67 %) of the participants reported prior contact with a nephrologist at study enrollment. They were younger, more likely to be male, non-Hispanic white, and had lower eGFR and higher urine protein (p < 0.05). A subgroup with eGFR 30– < 60 ml/min/1.73 m2 and prior contact with a nephrologist were more likely to receive pharmacologic treatment for CKD-related complications and to report angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (ACEi/ARB) use. After propensity score matching (for reporting prior contact with a nephrologist vs. not) and adjusting for demographic and clinical variables, prior contact with a nephrologist was not significantly associated with CKD progression, incident CVD or death (p > 0.05).

CONCLUSIONS

One-third of CRIC participants had not seen a nephrologist before enrollment, and this prior contact was subject to age, sex, and ethnic-related disparities. While prior nephrology care was associated with more frequent treatment of CKD complications and use of ACEi/ARB medications, there was neither an association between this care and achievement of guideline-recommended intermediate measures, nor long-term adverse outcomes.
Appendix
Available only for authorised users
Literature
1.
go back to reference K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39: S1-266. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39: S1-266.
2.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Inter., Suppl. 2013; 3: 1–150. 2013. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Inter., Suppl. 2013; 3: 1–150. 2013.
3.
go back to reference Smart NA, Titus TT. Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am J Med. 2011;124:1073–1080.PubMedCrossRef Smart NA, Titus TT. Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am J Med. 2011;124:1073–1080.PubMedCrossRef
4.
go back to reference Smart NA, Dieberg G, Ladhani M, Titus T. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst Rev. 2014;6, CD007333.PubMed Smart NA, Dieberg G, Ladhani M, Titus T. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst Rev. 2014;6, CD007333.PubMed
5.
go back to reference Avorn J, Bohn RL, Levy E, et al. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002;162:2002–2006.PubMedCrossRef Avorn J, Bohn RL, Levy E, et al. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002;162:2002–2006.PubMedCrossRef
6.
go back to reference Chan MR, Dall AT, Fletcher KE, Lu N, Trivedi H. Outcomes in patients with chronic kidney disease referred late to nephrologists: a meta-analysis. Am J Med. 2007;120:1063–1070.PubMedCrossRef Chan MR, Dall AT, Fletcher KE, Lu N, Trivedi H. Outcomes in patients with chronic kidney disease referred late to nephrologists: a meta-analysis. Am J Med. 2007;120:1063–1070.PubMedCrossRef
7.
go back to reference Khan SS, Xue JL, Kazmi WH, et al. Does predialysis nephrology care influence patient survival after initiation of dialysis? Kidney Int. 2005;67:1038–1046.PubMedCrossRef Khan SS, Xue JL, Kazmi WH, et al. Does predialysis nephrology care influence patient survival after initiation of dialysis? Kidney Int. 2005;67:1038–1046.PubMedCrossRef
8.
go back to reference Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137:479–486.PubMedCrossRef Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137:479–486.PubMedCrossRef
9.
go back to reference Stack AG. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis. 2003;41:310–318.PubMedCrossRef Stack AG. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis. 2003;41:310–318.PubMedCrossRef
10.
go back to reference Tseng CL, Kern EF, Miller DR, et al. Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease. Arch Intern Med. 2008;168:55–62.PubMedCrossRef Tseng CL, Kern EF, Miller DR, et al. Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease. Arch Intern Med. 2008;168:55–62.PubMedCrossRef
11.
go back to reference Orlando LA, Owen WF, Matchar DB. Relationship between nephrologist care and progression of chronic kidney disease. N C Med J. 2007;68:9–16.PubMed Orlando LA, Owen WF, Matchar DB. Relationship between nephrologist care and progression of chronic kidney disease. N C Med J. 2007;68:9–16.PubMed
12.
go back to reference Jones C, Roderick P, Harris S, Rogerson M. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant. 2006;21:2133–2143.PubMedCrossRef Jones C, Roderick P, Harris S, Rogerson M. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant. 2006;21:2133–2143.PubMedCrossRef
13.
go back to reference Martinez-Ramirez HR, Jalomo-Martinez B, Cortes-Sanabria L, et al. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist. Am J Kidney Dis. 2006;47:78–87.PubMedCrossRef Martinez-Ramirez HR, Jalomo-Martinez B, Cortes-Sanabria L, et al. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist. Am J Kidney Dis. 2006;47:78–87.PubMedCrossRef
14.
go back to reference Chen SC, Chang JM, Chou MC, et al. Slowing renal function decline in chronic kidney disease patients after nephrology referral. Nephrology (Carlton). 2008;13:730–736.CrossRef Chen SC, Chang JM, Chou MC, et al. Slowing renal function decline in chronic kidney disease patients after nephrology referral. Nephrology (Carlton). 2008;13:730–736.CrossRef
15.
go back to reference Feldman HI, Appel LJ, Chertow GM, et al. The chronic renal insufficiency cohort (CRIC) study: design and methods. J Am Soc Nephrol. 2003;14:S148–S153.PubMedCrossRef Feldman HI, Appel LJ, Chertow GM, et al. The chronic renal insufficiency cohort (CRIC) study: design and methods. J Am Soc Nephrol. 2003;14:S148–S153.PubMedCrossRef
16.
go back to reference Lash JP, Go AS, Appel LJ, et al. Chronic renal insufficiency cohort (CRIC) study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009;4:1302–1311.PubMedPubMedCentralCrossRef Lash JP, Go AS, Appel LJ, et al. Chronic renal insufficiency cohort (CRIC) study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009;4:1302–1311.PubMedPubMedCentralCrossRef
17.
go back to reference Fischer MJ, Go AS, Lora CM, et al. CKD in Hispanics: baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC studies. Am J Kidney Dis. 2011;58:214–227.PubMedPubMedCentralCrossRef Fischer MJ, Go AS, Lora CM, et al. CKD in Hispanics: baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC studies. Am J Kidney Dis. 2011;58:214–227.PubMedPubMedCentralCrossRef
18.
go back to reference K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42: S1-201. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42: S1-201.
19.
go back to reference K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004; 43: S1-290. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004; 43: S1-290.
20.
go back to reference II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis. 2006; 47: S16-S85. II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis. 2006; 47: S16-S85.
21.
go back to reference Anderson AH, Yang W, Hsu CY, et al. Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis. 2012;60:250–261.PubMedPubMedCentralCrossRef Anderson AH, Yang W, Hsu CY, et al. Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis. 2012;60:250–261.PubMedPubMedCentralCrossRef
22.
go back to reference Campbell KH, Smith SG, Hemmerich J, et al. Patient and provider determinants of nephrology referral in older adults with severe chronic kidney disease: a survey of provider decision making. BMC Nephrol. 2011;12:47.PubMedPubMedCentralCrossRef Campbell KH, Smith SG, Hemmerich J, et al. Patient and provider determinants of nephrology referral in older adults with severe chronic kidney disease: a survey of provider decision making. BMC Nephrol. 2011;12:47.PubMedPubMedCentralCrossRef
23.
go back to reference Saab G, Chen SC, Li S, et al. Association of physician care with mortality in Kidney Early Evaluation Program (KEEP) participants. Am J Kidney Dis. 2012;59:S34–S39.PubMedPubMedCentralCrossRef Saab G, Chen SC, Li S, et al. Association of physician care with mortality in Kidney Early Evaluation Program (KEEP) participants. Am J Kidney Dis. 2012;59:S34–S39.PubMedPubMedCentralCrossRef
24.
go back to reference Wauters JP, Lameire N, Davison A, Ritz E. Why patients with progressing kidney disease are referred late to the nephrologist: on causes and proposals for improvement. Nephrol Dial Transplant. 2005;20:490–496.PubMedCrossRef Wauters JP, Lameire N, Davison A, Ritz E. Why patients with progressing kidney disease are referred late to the nephrologist: on causes and proposals for improvement. Nephrol Dial Transplant. 2005;20:490–496.PubMedCrossRef
25.
go back to reference Wei LJ. Testing goodness of fit for proportional hazards model with censored observations. J Am Stat Assoc. 1984;79:649–652.CrossRef Wei LJ. Testing goodness of fit for proportional hazards model with censored observations. J Am Stat Assoc. 1984;79:649–652.CrossRef
26.
go back to reference Navaneethan SD, Kandula P, Jeevanantham V, Nally JV Jr, Liebman SE. Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients. Clin Nephrol. 2010;73:260–267.PubMedCrossRef Navaneethan SD, Kandula P, Jeevanantham V, Nally JV Jr, Liebman SE. Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients. Clin Nephrol. 2010;73:260–267.PubMedCrossRef
27.
go back to reference Boudville N, Muthucumarana K, Inderjeeth C. Limited referral to nephrologists from a tertiary geriatric outpatient clinic despite a high prevalence of chronic kidney disease and anaemia. BMC Geriatr. 2012;12:43.PubMedPubMedCentralCrossRef Boudville N, Muthucumarana K, Inderjeeth C. Limited referral to nephrologists from a tertiary geriatric outpatient clinic despite a high prevalence of chronic kidney disease and anaemia. BMC Geriatr. 2012;12:43.PubMedPubMedCentralCrossRef
28.
go back to reference Montgomery AJ, McGee HM, Shannon W, Donohoe J. Factors influencing general practitioner referral of patients developing end-stage renal failure: a standardised case-analysis study. BMC Health Serv Res. 2006;6:114.PubMedPubMedCentralCrossRef Montgomery AJ, McGee HM, Shannon W, Donohoe J. Factors influencing general practitioner referral of patients developing end-stage renal failure: a standardised case-analysis study. BMC Health Serv Res. 2006;6:114.PubMedPubMedCentralCrossRef
29.
go back to reference Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR. Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis. 2006;48:192–204.PubMedCrossRef Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR. Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis. 2006;48:192–204.PubMedCrossRef
30.
go back to reference Winkelmayer WC, Liu J, Chertow GM, Tamura MK. Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med. 2011;171:1371–1378.PubMedPubMedCentralCrossRef Winkelmayer WC, Liu J, Chertow GM, Tamura MK. Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med. 2011;171:1371–1378.PubMedPubMedCentralCrossRef
31.
go back to reference Hoy T, Fisher M, Barber B, Borker R, Stolshek B, Goodman W. Adherence to K/DOQI practice guidelines for bone metabolism and disease. Am J Manage Care. 2007;13:620–625. Hoy T, Fisher M, Barber B, Borker R, Stolshek B, Goodman W. Adherence to K/DOQI practice guidelines for bone metabolism and disease. Am J Manage Care. 2007;13:620–625.
32.
go back to reference Cleveland DR, Jindal KK, Hirsch DJ, Kiberd BA. Quality of prereferral care in patients with chronic renal insufficiency. Am J Kidney Dis. 2002;40:30–36.PubMedCrossRef Cleveland DR, Jindal KK, Hirsch DJ, Kiberd BA. Quality of prereferral care in patients with chronic renal insufficiency. Am J Kidney Dis. 2002;40:30–36.PubMedCrossRef
33.
go back to reference Patwardhan MB, Samsa GP, Matchar DB, Haley WE. Advanced chronic kidney disease practice patterns among nephrologists and non-nephrologists: a database analysis. Clin J Am Soc Nephrol. 2007;2:277–283.PubMedCrossRef Patwardhan MB, Samsa GP, Matchar DB, Haley WE. Advanced chronic kidney disease practice patterns among nephrologists and non-nephrologists: a database analysis. Clin J Am Soc Nephrol. 2007;2:277–283.PubMedCrossRef
34.
go back to reference Philipneri MD, Rocca Rey LA, Schnitzler MA, et al. Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol. 2008;12:41–52.PubMedCrossRef Philipneri MD, Rocca Rey LA, Schnitzler MA, et al. Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol. 2008;12:41–52.PubMedCrossRef
35.
go back to reference Winkelmayer WC, Levin R, Avorn J. The nephrologist's role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease. Kidney Int. 2003;63:1836–1842.PubMedCrossRef Winkelmayer WC, Levin R, Avorn J. The nephrologist's role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease. Kidney Int. 2003;63:1836–1842.PubMedCrossRef
36.
go back to reference Curtis BM, Barrett BJ, Djurdjev O, Singer J, Levin A. Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada. Am J Kidney Dis. 2007;50:733–742.PubMedCrossRef Curtis BM, Barrett BJ, Djurdjev O, Singer J, Levin A. Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada. Am J Kidney Dis. 2007;50:733–742.PubMedCrossRef
Metadata
Title
Influence of Nephrologist Care on Management and Outcomes in Adults with Chronic Kidney Disease
Authors
Ana C. Ricardo, MD, MPH
Jason A. Roy, PhD
Kaixiang Tao, PhD
Arnold Alper, MD, MPH
Jing Chen, MD, MSc
Paul E. Drawz, MD, MHS
Jeffrey C. Fink, MD, MS
Chi-yuan Hsu, MD, MSc
John W. Kusek, PhD
Akinlolu Ojo, MD, PhD
Martin Schreiber, MD
Michael J. Fischer, MD, MSPH
on behalf of the CRIC Study Investigators
Publication date
01-01-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 1/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3452-x

Other articles of this Issue 1/2016

Journal of General Internal Medicine 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine